ストックスクリーナーアプリを入手
60.77
1.81%
-1.12
アフターアワーズ：
59.96
-0.81
-1.33%
Crispr Therapeutics Ag (CRSP) 最新ニュース
CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors - Yahoo Finance
Over 2 Billion Reasons to Love CRISPR Therapeutics Right Now - The Motley Fool
CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026? - The Motley Fool
CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? - AOL.com
CRSPCRISPR Therapeutics AG Options - Finviz
CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Citizens reiterates CRISPR Therapeutics stock rating on label expansion potential - Investing.com
Does CRISPR Therapeutics’ (CRSP) Russell Index Debut Quietly Reframe Its Biotech Growth Narrative? - simplywall.st
symbol__ Stock Quote Price and Forecast - CNN
CRISPR Therapeutics (CRSP) Price Forecast: Dual Breakout Targets Higher Prices - FXEmpire
CRISPR Therapeutics (CRSP) Is Up 11.3% After Broad Russell Growth Index Inclusion Has The Bull Case Changed? - Yahoo Finance
Crispr Therapeutics: Casgevy's Pediatric Win A Trigger For Bullish Sentiment - Seeking Alpha
CRSP News | CRISPR THERAPEUTICS AG (NASDAQ:CRSP) - ChartMill
CRSP Stock Pops As Morgan Stanley Doubles Price Target - timothysykes.com
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know - Yahoo Finance
CRISPR Therapeutics AG(NasdaqGM:CRSP) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
CRISPR Therapeutics AG(NasdaqGM: CRSP) added to Russell 2500 Growth Benchmark - marketscreener.com
ETFs Investing in CRISPR Therapeutics AG Stocks - TradingView
CRISPR Therapeutics AG(NasdaqGM: CRSP) added to Russell 2000 Growth Benchmark - marketscreener.com
CRISPR Therapeutics AG(NasdaqGM: CRSP) added to Russell 3000E Growth Benchmark - marketscreener.com
CRISPR Therapeutics AG(NasdaqGM: CRSP) added to Russell 3000 Growth Benchmark - marketscreener.com
Price to sales forward of CRISPR Therapeutics AG – NASDAQ:CRSP - TradingView
Price to sales forward of CRISPR Therapeutics AG – DUS:1CG - TradingView
Price to book forward of CRISPR Therapeutics AG – NASDAQ:CRSP - TradingView
Price to earnings forward of CRISPR Therapeutics AG – NASDAQ:CRSP - TradingView
CRISPR Therapeutics AG vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Price to book forward of CRISPR Therapeutics AG – DUS:1CG - TradingView
Enterprise value to revenue forward of CRISPR Therapeutics AG – NASDAQ:CRSP - TradingView
The Best Stocks to Invest $1,000 in Right Now - AOL.com
Enterprise value to revenue forward of CRISPR Therapeutics AG – DUS:1CG - TradingView
Enterprise value to EBITDA forward of CRISPR Therapeutics AG – NASDAQ:CRSP - TradingView
Enterprise value to EBIT forward of CRISPR Therapeutics AG – NASDAQ:CRSP - TradingView
CRISPR Therapeutics AG (CRSP) advances while market declines: Some information for investors - MSN
CRISPR Therapeutics AG (CRSP) Advances While Market Declines: Some Information for Investors - Yahoo Finance
Is CRISPR Therapeutics (CRSP) Finally Ready for Prime Time After Casgevy's Initial Success - Kavout | AI
Beam Therapeutics: A Better Entry Point Is Likely Coming (Rating Downgrade) (NASDAQ:BEAM) - Seeking Alpha
CRISPR Therapeutics AG Actuals & Estimates (NASDAQ:CRSP) - TradingView
CRSP Forecast — Price Target — Prediction for 2027 - TradingView
3 Companies Redefining Healthcare Innovation - Seeking Alpha
CRISPR Therapeutics AG (CRSP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CRISPR Therapeutics clears a key chart level, shares trade higher on NASDAQ - Ad-hoc-news.de
CRISPR Therapeutics AG (CRSP) falls more steeply than broader market: What investors need to know - MSN
CRISPR Therapeutics (CRSP) TD Cowen 46th Annual Health Care Conference Summary - Quartr
CRISPR Therapeutics (CRSP) Stock Could Be 69.5% Below Fair Value After Recent Gains - Sahm
CRISPR Therapeutics StockWeekly review against gene-editing peers - AD HOC NEWS
CRISPR Therapeutics AG (CRSP) is a trending stock: Facts to know before betting on it - MSN
CRISPR Therapeutics Faces Market Challenges Amid Progress - Intellectia AI
Why CRISPR Therapeutics Stock Has Been on a Roller-Coaster Ride This Year - The Motley Fool
CRISPR Therapeutics AG (CRSP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CRISPR Therapeutics AG (CRSP) Institutional Confidence - TradingKey
CRISPR Therapeutics AG (CRSP) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
The Best Biotech Stocks to Buy in 2026 - The Motley Fool
CRISPR Therapeutics AG (CRSP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Is CRISPR Therapeutics’ (CRSP) ESOP Shelf Registration Quietly Redefining Its Long‑Term Risk‑Reward Profile? - simplywall.st
CRISPR Therapeutics AG (CRSP) is attracting investor attention: Here is what you should know - MSN
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Why is CRISPR Therapeutics (CRSP) down 0.7% since last earnings report? - MSN
CRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release - Eastern Progress
Understanding the Setup: (CRSP) and Scalable Risk - Stock Traders Daily
28,037 Shares in CRISPR Therapeutics AG $CRSP Bought by Blue Jean Financial LLC - MarketBeat
CRISPR Therapeutics stock is absurdly cheap -- here's why analysts see 437% upside potential - MSN
1.17%
2.48%
大文字化:
|
ボリューム (24 時間):